EPISODE · Jan 18, 2026 · 54 MIN
Episode 93: From ICU to 100,000 Patients: Building the Future of Personalized Medicine
from The DNA of Things with Dr. Jeremy Koenig
In this episode, Chris Spears, founder of OrderlyMeds, shares his transformative journey from a catastrophic ICU experience to building a human-centered medication management platform that's revolutionizing personalized healthcare. Chris opens up about his frustrating odyssey through the broken healthcare system, the worst telemedicine experience of his life, and how those challenges sparked the creation of a company that's now serving over 90,000 patients monthly. This conversation explores the intersection of GLP-1 medications, DNA insights, AI-powered health data, and the future of precision medicine—revealing how one person's struggle became a mission to help millions thrive in the second half of life.Key Takeaways🏥 The healthcare system's blindness to patient experience created an opportunity for innovation—Chris transformed his worst customer service experience into a solution that now helps 90,000+ people manage their medication journey💉 GLP-1 medication shortages persist across America despite high demand—even two years later, many pharmacies still run out within days of receiving shipments🚀 Rapid scaling is possible with the right mission—OrderlyMeds grew from 17 customers in January 2024 to 60,000 monthly active patients by late 2025, adding 6,000-10,000 new patients each month🧬 DNA markers can predict GLP-1 response—genetic testing helps determine whether these life-changing medications will actually work for you before making the investment🔬 The future of healthcare is data integration—combining DNA, blood work, gut biome, wearable tech, and clinical data will enable truly personalized medicine at scale🤖 AI augments rather than replaces healthcare providers—technology can handle 80% of routine analysis, freeing humans to apply clinical judgment and compassion where it matters most💰 Financial investment drives adherence—cash-pay patients show higher medication compliance than insurance-covered patients, suggesting skin in the game matters for health outcomes👨👩👧👦 Building with friends and family creates accountability—surrounding yourself with trusted people who believe in your mission strengthens both culture and execution📱 Nine disconnected health apps create a new data problem—the next challenge is integrating fragmented health information into a single source of truth for consumers🎯 Personalized medicine requires personalized compounding—the future means your medication formulation will differ from others based on your unique biology⚡ Testosterone therapy remains stigmatized despite its benefits—only one in eight men who could benefit from testosterone replacement actually pursue it due to ego and shame🌟 Thriving in the second half of life is the real goal—weight loss and medication management are tools to help people keep up with grandkids, travel with partners, and enjoy life fully LINKS:https://www.drjeremykoenig.com/https://www.instagram.com/drjeremykoenig/https://www.youtube.com/@drjeremykoenigHere's the link for this week's episode: https://drjeremykoenig.substack.com/.
Embed this episode
What this episode covers
In this episode, Chris Spears, founder of OrderlyMeds, shares his transformative journey from a catastrophic ICU experience to building a human-centered medication management platform that's revolutionizing personalized healthcare. Chris opens up about his frustrating odyssey through the broken healthcare system, the worst telemedicine experience of his life, and how those challenges sparked the creation of a company that's now serving over 90,000 patients monthly. This conversation explores ...
NOW PLAYING
Episode 93: From ICU to 100,000 Patients: Building the Future of Personalized Medicine
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.